These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 9354442

  • 1. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
    Kadhim SA, Bowlin TL, Waud WR, Angers EG, Bibeau L, DeMuys JM, Bednarski K, Cimpoia A, Attardo G.
    Cancer Res; 1997 Nov 01; 57(21):4803-10. PubMed ID: 9354442
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G.
    Cancer Chemother Pharmacol; 2002 Dec 01; 50(6):490-6. PubMed ID: 12451476
    [Abstract] [Full Text] [Related]

  • 3. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
    Rabbani SA, Harakidas P, Bowlin T, Attardo G.
    Cancer Res; 1998 Aug 01; 58(15):3461-5. PubMed ID: 9699681
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P.
    Anticancer Res; 1999 Aug 01; 19(1A):493-504. PubMed ID: 10226588
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
    Plonowski A, Schally AV, Nagy A, Kiaris H, Hebert F, Halmos G.
    Cancer Res; 2000 Jun 01; 60(11):2996-3001. PubMed ID: 10850448
    [Abstract] [Full Text] [Related]

  • 6. Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.
    Knoll K, Wrasidlo W, Scherberich JE, Gaedicke G, Fischer P.
    Cancer Res; 2000 Nov 01; 60(21):6089-94. PubMed ID: 11085532
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity of renal cell carcinoma to aminoflavone: role of CYP1A1.
    Loaiza-Pérez AI, Kenney S, Boswell J, Hollingshead M, Hose C, Linehan WM, Worrell R, Rubinstein L, Sausville EA, Vistica DT.
    J Urol; 2004 Apr 01; 171(4):1688-97. PubMed ID: 15017268
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effects of an imidazoquinoline in renal cell carcinoma.
    Schwartz MJ, Liu H, Hwang DH, Kawamoto H, Scherr DS.
    Urology; 2009 May 01; 73(5):1156-62. PubMed ID: 19118885
    [Abstract] [Full Text] [Related]

  • 9. Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration.
    Grove KL, Guo X, Liu SH, Gao Z, Chu CK, Cheng YC.
    Cancer Res; 1995 Jul 15; 55(14):3008-11. PubMed ID: 7606719
    [Abstract] [Full Text] [Related]

  • 10. Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity.
    Gourdeau H, Bibeau L, Ouellet F, Custeau D, Bernier L, Bowlin T.
    Cancer Chemother Pharmacol; 2001 Mar 15; 47(3):236-40. PubMed ID: 11320667
    [Abstract] [Full Text] [Related]

  • 11. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 12. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
    Prewett M, Rothman M, Waksal H, Feldman M, Bander NH, Hicklin DJ.
    Clin Cancer Res; 1998 Dec 15; 4(12):2957-66. PubMed ID: 9865906
    [Abstract] [Full Text] [Related]

  • 13. Species differences in troxacitabine pharmacokinetics and pharmacodynamics: implications for clinical development.
    Gourdeau H, Leblond L, Hamelin B, Dong K, Ouellet F, Boudreau C, Custeau D, Richard A, Gilbert MJ, Jolivet J.
    Clin Cancer Res; 2004 Nov 15; 10(22):7692-702. PubMed ID: 15570003
    [Abstract] [Full Text] [Related]

  • 14. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
    Pratesi G, De Cesare M, Carenini N, Perego P, Righetti SC, Cucco C, Merlini L, Pisano C, Penco S, Carminati P, Vesci L, Zunino F.
    Clin Cancer Res; 2002 Dec 15; 8(12):3904-9. PubMed ID: 12473606
    [Abstract] [Full Text] [Related]

  • 15. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.
    Cancer Chemother Pharmacol; 2009 Jun 15; 64(1):53-65. PubMed ID: 18931998
    [Abstract] [Full Text] [Related]

  • 16. Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.
    Drees M, Dengler WA, Roth T, Labonte H, Mayo J, Malspeis L, Grever M, Sausville EA, Fiebig HH.
    Clin Cancer Res; 1997 Feb 15; 3(2):273-9. PubMed ID: 9815683
    [Abstract] [Full Text] [Related]

  • 17. Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models.
    Schirner M, Hoffmann J, Menrad A, Schneider MR.
    Clin Cancer Res; 1998 May 15; 4(5):1331-6. PubMed ID: 9607594
    [Abstract] [Full Text] [Related]

  • 18. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H, Senba H, Virgona N, Fukumoto K, Ishida T, Hagiwara H, Negishi E, Ueno K, Yamasaki H, Yano T.
    Mol Carcinog; 2007 Mar 15; 46(3):215-24. PubMed ID: 17186540
    [Abstract] [Full Text] [Related]

  • 19. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
    Hattori H, Tanaka M, Fukushima M, Sasaki T, Matsuda A.
    J Med Chem; 1996 Dec 06; 39(25):5005-11. PubMed ID: 8960561
    [Abstract] [Full Text] [Related]

  • 20. The alkylator treosulfan shows activity towards human renal-cell carcinoma in vivo and in vitro.
    Köpf-Maier P.
    In Vivo; 1998 Dec 06; 12(3):275-88. PubMed ID: 9706471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.